Ameritas Investment Partners, Inc.
Position in DMRA — Damora Therapeutics, Inc.
CIK 1055980
LINCOLN, NE
Position in DMRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$126,018
New position
Shares Held
4,845
first reported quarter
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 104 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ameritas Investment Partners, Inc. holds $63,306,181 across 267 Biotechnology names. DMRA ranks #90 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,422 | $6,170,379 | |
| 2 | EXEL |
Exelixis, Inc.
|
75,969 | $4,133,473 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
40,729 | $3,187,858 | |
| 4 | CYTK |
Cytokinetics Inc
|
36,992 | $3,151,348 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
83,064 | $2,939,634 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,593 | $2,863,919 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
11,547 | $2,782,480 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
25,923 | $2,112,983 |
All Filings in DMRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $126,018 | 4,845 | Shares | Other | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||